Submit Release
News Search

There were 2,025 press releases posted in the last 24 hours and 440,631 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Le masitinib reçoit la désignation de médicament orphelin pour le traitement de la sclérose latérale amyotrophique en Suisse

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image

By continuing to use this site, you agree to our Terms & Conditions, last updated on September 30, 2025.

We use cookies to enhance your experience. Learn more